おすすめの製品
品質水準
アッセイ
≥97.0% (HPCE)
フォーム
powder
溶解性
ethanol: soluble
蛍光検出
λex 490 nm; λem 514 nm in 0.1 M Tris pH 8.0 (esterase)
適合性
suitable for fluorescence
SMILES記法
CCCCCCCCCCCC(=O)Oc1ccc2c(Oc3cc(OC(=O)CCCCCCCCCCC)ccc3C24OC(=O)c5ccccc45)c1
InChI
1S/C44H56O7/c1-3-5-7-9-11-13-15-17-19-25-41(45)48-33-27-29-37-39(31-33)50-40-32-34(49-42(46)26-20-18-16-14-12-10-8-6-4-2)28-30-38(40)44(37)36-24-22-21-23-35(36)43(47)51-44/h21-24,27-32H,3-20,25-26H2,1-2H3
InChI Key
MYTRGBGGRICZGN-UHFFFAOYSA-N
類似した製品をお探しですか？ 訪問 製品比較ガイド
アプリケーション
Fluorescein dilaurate is suitable as fluorogenic substrate for esterases/lipases and used in the pancreolauryl test for chronic pancreatitis.
保管分類コード
11 - Combustible Solids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
個人用保護具 (PPE)
Eyeshields, Gloves, type N95 (US)
この製品を見ている人はこちらもチェック
J E Domínguez-Muñoz et al.
Clinical chemistry, 44(4), 869-875 (1998-05-15)
The serum pancreolauryl test has limited sensitivity for detecting mild pancreatic insufficiency. The aim of this study was to optimize the serum pancreolauryl test so as to increase the probability of positive results in patients with chronic pancreatitis. The study
J E Domínguez-Muñoz et al.
The American journal of gastroenterology, 88(8), 1237-1241 (1993-08-01)
Indirect pancreatic function tests are frequently used in the clinical routine as complementary tools for the diagnosis of chronic pancreatitis (CP) because of their noninvasiveness and simplicity. We analyzed the clinical efficacy and routine application of a modified serum pancreolauryl
A perspective on the use of tubeless pancreatic function tests in diagnosis.
E P DiMagno
Gut, 43(1), 2-3 (1998-10-15)
F M Stevens et al.
Journal of clinical pathology, 50(12), 1001-1004 (1998-03-28)
To determine the frequency of abnormal pancreolauryl tests in untreated and treated adults with coeliac disease and to see whether abnormalities in treated coeliac patients correlate with the degree of recovery of intestinal morphology or brush border enzyme activity. Pancreolauryl
F Seibold et al.
Journal of clinical gastroenterology, 22(3), 202-206 (1996-04-01)
Pancreatic autoantibodies (PABs) are found in 31% of patients with Crohn's disease (CD), but they do not correlate with the activity of intestinal disease or the incidence of acute pancreatitis. Exocrine pancreatic insufficiency has been observed in patients with CD.
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）